Pathologic examination of sentinel lymph node for breast carcinoma

World Journal of Surgery

Volumn 25, Issue 6, 2001, Pages 798-805

  Turner, Roderick R ^a   Giuliano, Armando E ^a   Hoon, Dave S B ^b   Glass, Edwin C ^a   Krasne, David L ^b  

^a JOHN WAYNE CANCER INSTITUTE   (United States)

^b SAINT JOHN'S HEALTH CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN;

ARTICLE; BREAST CARCINOMA; CANCER DIAGNOSIS; CANCER STAGING; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; PROGNOSIS; SENTINEL LYMPH NODE;

BREAST NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; KERATINS; LYMPH NODES; LYMPHATIC METASTASIS; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SENTINEL LYMPH NODE BIOPSY;

EID: 0035016644     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-001-0008-5     Document Type: Article

References (63)

1. Technical details of intraoperative lymphatic mapping for early stage melanoma
2. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
3. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe
4. Lymphatic mapping and sentinel node biopsy in the patient with breast cancer
5. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph nodes
6. Improved axillary staging of breast cancer with sentinel lymphadenectomy
7. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer
8. Sentinel lymphadenectomy in breast cancer
9. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer
10. The sentinel node in breast cancer: A multi-center validation study
11. Histopathologic validation of the sentinel lymph node hypothesis for breast carcinoma
12. The effect of routine methods of processing lymph nodes on the number of metastases detected in women with breast cancer
13. The surgical pathology report: Standardizing the "gold standard"
14. Guidelines for the safe use of radioactive materials during the localization and resection of the sentinel lymph node
15. Radiation safety considerations for sentinel node techniques
16. Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction
17. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction
18. Clinical significance of bone marrow metastases as detected using the polymerase chain reaction in patients with breast cancer undergoing high dose chemotherapy and autologous bone marrow transplantation
19. Clinical significance of molecular detection of carcinoma cells in lymph nodes and peripheral blood by reverse transcription-polymerase chain reaction in patients with gastrointestinal or breast carcinomas
20. The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction
21. Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients
22. Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes
23. Detection of occult breast cancer micrometastases in axillary lymph nodes using a multi-marker reverse transcriptase-polymerase chain reaction panel
24. Detection of metastatic breast cancer by B-hCG polymerase chain reaction
25. Submission of lymph node tissue for ancillary studies decreases the accuracy of conventional breast cancer axillary node staging
26. Detection of metastases in sentinel lymph nodes of breast cancer patients by multiple-marker RT-PCR
27. Probability in lymph node sectioning
28. The routine histological investigation of axillary lymph nodes for metastatic breast cancer
29. Review. Lymphatic mapping and sentinel node biopsy in breast cancer
30. Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance
31. Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance
32. Lymph node imprint cytology for the rapid assessment of axillary node metastases in breast cancer
33. Intraoperative imprint cytology of sentinel lymph nodes in breast cancer
34. Use of touch preps for intraoperative diagnosis of sentinel lymph node metastases in breast cancer
35. Sentinel node localization in patients with breast cancer
36. Intraoperative pathologic examination of the sentinel lymph node
37. Intraoperative frozen section examination of the sentinel lymph node for breast carcinoma staging
38. A rapid immunostaining method for frozen sections
39. Evaluation of sentinel lymph node imprints in breast cancer: Role of intraoperative cytokeratin immunostaining in breast cancer staging
40. Intraoperative examination of axillary sentinel nodes in breast cancer
41. Prognostic importance of occult axillary lymph node micrometastases from breast cancers
42. Axillary node micrometastases and breast cancer
43. Occult axillary node metastases in breast cancer: Their detection and prognostic significance
44. Prognostic significance of occult lymph node metastases in node-negative breast cancer
45. Micrometastases to axillary lymph nodes from carcinoma of breast: Detection by immunohistochemistry and prognostic significance
46. Lymph node micrometastases from breast cancer: Reviewing the dilemma
47. Clinical relevance of serial sectioning of sentinel nodes and the detection of micrometastatic nodal disease in breast cancer
48. Serial sectioning of sentinel nodes in patients with breast cancer: A pilot study
49. Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabeled dextran
50. Optimal histopathologic examination of the sentinel lymph node for breast carcinoma staging
51. Cytokeratin-immunoreactive cells of human lymph nodes and spleen in normal and pathological conditions: An immunohistochemical study
52. The fate of bone marrow micrometastases in patients with primary breast cancer
53. Epithelial displacement in surgical breast specimens following needling procedures
54. Is surgical manipulation preceding mastectomy affecting the micrometastasis rate?
55. Pathology of axillary and intramammary lymph nodes
56. Multilevel sectioning of sentinel lymph nodes: Role in breast cancer staging?
57. Prognosis in breast cancer patients with tumor cells in the efferent vessels of their axillary nodes
58. Prognostic features in patients with stage T1 breast carcinoma and a 0.5 cm or less lymph node metastasis
59. Breast cancer: Two micrometastatic variants in the axilla that differ in prognosis
60. Do all patients with sentinel node metastasis from breast carcinoma need complete axillary node dissection?
61. Pathologic features associated with nonsentinel lymph node metastases in patients with metastatic breast carcinoma in a sentinel lymph node
62. Therapeutic effect of sentinel lymphadenectomy in T1 breast cancer